51. Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
- Author
-
Rodoni D, Hänni F, Gerber CM, Cottagnoud M, Neftel K, Täuber MG, and Cottagnoud P
- Subjects
- Animals, Anti-Bacterial Agents cerebrospinal fluid, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Anti-Infective Agents cerebrospinal fluid, Anti-Infective Agents pharmacology, Disease Models, Animal, Drug Therapy, Combination, Meningitis, Pneumococcal metabolism, Naphthyridines cerebrospinal fluid, Naphthyridines pharmacology, Penicillin Resistance, Rabbits, Streptococcus pneumoniae drug effects, Time Factors, Vancomycin cerebrospinal fluid, Vancomycin pharmacology, Anti-Infective Agents therapeutic use, Fluoroquinolones, Meningitis, Pneumococcal drug therapy, Naphthyridines therapeutic use, Vancomycin therapeutic use
- Abstract
Trovafloxacin, a new fluoroquinolone, produced bactericidal activity (-0.33 +/- 0.13 delta log10 CFU/ml.h; intravenously [i.v.] administered dose, 15 mg/kg) comparable to that of vancomycin (-0.39 +/- 0.18 delta log10 CFU/ml.h; i.v. admininistered dose, 20 mg/kg) in the treatment of experimental meningitis in rabbits due to a pneumococcal strain highly resistant to penicillin (MIC of penicillin G, 4 micrograms/ml). The combination of both drugs significantly increased (P < 0.05) the killing rate (-0.60 +/- 0.23 delta log10 CFU/ml.h) compared to that produced by either monotherapy. These results were also confirmed in vitro.
- Published
- 1999
- Full Text
- View/download PDF